BlackRock, Inc. 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-07 1:30 pm Purchase | 2024-05-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 10,124,431 10.700% | 3,857,458 (+61.55%) | Filing |
| 2024-01-26 5:26 pm Purchase | 2023-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 6,266,973 6.700% | 709,739 (+12.77%) | Filing |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 5,557,234 6.300% | 272,000 (+5.15%) | Filing |
| 2022-02-01 5:14 pm Sale | 2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 5,285,234 6.100% | -93,981 (-1.75%) | Filing |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 5,379,215 6.800% | 738,930 (+15.92%) | Filing |